Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

gastrin-producing neuroendocrine tumor - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

gastrin-producing neuroendocrine tumor

MONDO:0003523

Also known as:G cell tumorG cell tumourG-cell gastrin producing tumor

Find Clinical TrialsTrials

Overview

A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine.

Treatments2 FDA approved

Clinical Trials2 registered

Diagnosis

Biomarker and diagnostic research for gastrin-producing neuroendocrine tumor has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

2 FDA-approved treatments are available for gastrin-producing neuroendocrine tumor, including secreflo (SECREFLO, approved 2002) and HUMAN SECRETIN (CHIRHOSTIM, approved 2004). An additional 1 compound holds orphan drug designation.

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

2 clinical trials registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.

49 publications have been identified in PubMed for gastrin-producing neuroendocrine tumor. Research spans Case Report / Case Series (39%), Review / Meta-Analysis (27%), and Basic Science / Preclinical (10%).

Research Type	Count	% of Total
Patient case studies	19

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→What are the benefits and potential side effects of SECREFLO for managing gastrin-producing neuroendocrine tumor?
→Are any of the 2 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Kisho

gastrin-producing neuroendocrine tumor

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

Orphan Drug Designations

Clinical Trials

Recent Publications

gastrin-producing neuroendocrine tumor

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Orphan Drug Designations

Clinical Trials

Recent Publications